Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.

Axfors C, Schmitt AM, Janiaud P, Van't Hooft J, Abd-Elsalam S, Abdo EF, Abella BS, Akram J, Amaravadi RK, Angus DC, Arabi YM, Azhar S, Baden LR, Baker AW, Belkhir L, Benfield T, Berrevoets MAH, Chen CP, Chen TC, Cheng SH, Cheng CY, Chung WS, Cohen YZ, Cowan LN, Dalgard O, de Almeida E Val FF, de Lacerda MVG, de Melo GC, Derde L, Dubee V, Elfakir A, Gordon AC, Hernandez-Cardenas CM, Hills T, Hoepelman AIM, Huang YW, Igau B, Jin R, Jurado-Camacho F, Khan KS, Kremsner PG, Kreuels B, Kuo CY, Le T, Lin YC, Lin WP, Lin TH, Lyngbakken MN, McArthur C, McVerry BJ, Meza-Meneses P, Monteiro WM, Morpeth SC, Mourad A, Mulligan MJ, Murthy S, Naggie S, Narayanasamy S, Nichol A, Novack LA, O'Brien SM, Okeke NL, Perez L, Perez-Padilla R, Perrin L, Remigio-Luna A, Rivera-Martinez NE, Rockhold FW, Rodriguez-Llamazares S, Rolfe R, Rosa R, Røsjø H, Sampaio VS, Seto TB, Shahzad M, Soliman S, Stout JE, Thirion-Romero I, Troxel AB, Tseng TY, Turner NA, Ulrich RJ, Walsh SR, Webb SA, Weehuizen JM, Velinova M, Wong HL, Wrenn R, Zampieri FG, Zhong W, Moher D, Goodman SN, Ioannidis JPA, Hemkens LG

Open source

DOI
10.1038/s41467-021-22446-z
Published
2021 Apr 15
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-021-22446-z,
  title = {Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.},
  author = {Axfors C and Schmitt AM and Janiaud P and Van't Hooft J and Abd-Elsalam S and Abdo EF and Abella BS and Akram J and Amaravadi RK and Angus DC and Arabi YM and Azhar S and Baden LR and Baker AW and Belkhir L and Benfield T and Berrevoets MAH and Chen CP and Chen TC and Cheng SH and Cheng CY and Chung WS and Cohen YZ and Cowan LN and Dalgard O and de Almeida E Val FF and de Lacerda MVG and de Melo GC and Derde L and Dubee V and Elfakir A and Gordon AC and Hernandez-Cardenas CM and Hills T and Hoepelman AIM and Huang YW and Igau B and Jin R and Jurado-Camacho F and Khan KS and Kremsner PG and Kreuels B and Kuo CY and Le T and Lin YC and Lin WP and Lin TH and Lyngbakken MN and McArthur C and McVerry BJ and Meza-Meneses P and Monteiro WM and Morpeth SC and Mourad A and Mulligan MJ and Murthy S and Naggie S and Narayanasamy S and Nichol A and Novack LA and O'Brien SM and Okeke NL and Perez L and Perez-Padilla R and Perrin L and Remigio-Luna A and Rivera-Martinez NE and Rockhold FW and Rodriguez-Llamazares S and Rolfe R and Rosa R and Røsjø H and Sampaio VS and Seto TB and Shahzad M and Soliman S and Stout JE and Thirion-Romero I and Troxel AB and Tseng TY and Turner NA and Ulrich RJ and Walsh SR and Webb SA and Weehuizen JM and Velinova M and Wong HL and Wrenn R and Zampieri FG and Zhong W and Moher D and Goodman SN and Ioannidis JPA and Hemkens LG},
  year = {2021},
  journal = {Nature communications},
  doi = {10.1038/s41467-021-22446-z},
  url = {https://doi.org/10.1038/s41467-021-22446-z}
}

RIS

TY  - JOUR
TI  - Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
AU  - Axfors C
AU  - Schmitt AM
AU  - Janiaud P
AU  - Van't Hooft J
AU  - Abd-Elsalam S
AU  - Abdo EF
AU  - Abella BS
AU  - Akram J
AU  - Amaravadi RK
AU  - Angus DC
AU  - Arabi YM
AU  - Azhar S
AU  - Baden LR
AU  - Baker AW
AU  - Belkhir L
AU  - Benfield T
AU  - Berrevoets MAH
AU  - Chen CP
AU  - Chen TC
AU  - Cheng SH
AU  - Cheng CY
AU  - Chung WS
AU  - Cohen YZ
AU  - Cowan LN
AU  - Dalgard O
AU  - de Almeida E Val FF
AU  - de Lacerda MVG
AU  - de Melo GC
AU  - Derde L
AU  - Dubee V
AU  - Elfakir A
AU  - Gordon AC
AU  - Hernandez-Cardenas CM
AU  - Hills T
AU  - Hoepelman AIM
AU  - Huang YW
AU  - Igau B
AU  - Jin R
AU  - Jurado-Camacho F
AU  - Khan KS
AU  - Kremsner PG
AU  - Kreuels B
AU  - Kuo CY
AU  - Le T
AU  - Lin YC
AU  - Lin WP
AU  - Lin TH
AU  - Lyngbakken MN
AU  - McArthur C
AU  - McVerry BJ
AU  - Meza-Meneses P
AU  - Monteiro WM
AU  - Morpeth SC
AU  - Mourad A
AU  - Mulligan MJ
AU  - Murthy S
AU  - Naggie S
AU  - Narayanasamy S
AU  - Nichol A
AU  - Novack LA
AU  - O'Brien SM
AU  - Okeke NL
AU  - Perez L
AU  - Perez-Padilla R
AU  - Perrin L
AU  - Remigio-Luna A
AU  - Rivera-Martinez NE
AU  - Rockhold FW
AU  - Rodriguez-Llamazares S
AU  - Rolfe R
AU  - Rosa R
AU  - Røsjø H
AU  - Sampaio VS
AU  - Seto TB
AU  - Shahzad M
AU  - Soliman S
AU  - Stout JE
AU  - Thirion-Romero I
AU  - Troxel AB
AU  - Tseng TY
AU  - Turner NA
AU  - Ulrich RJ
AU  - Walsh SR
AU  - Webb SA
AU  - Weehuizen JM
AU  - Velinova M
AU  - Wong HL
AU  - Wrenn R
AU  - Zampieri FG
AU  - Zhong W
AU  - Moher D
AU  - Goodman SN
AU  - Ioannidis JPA
AU  - Hemkens LG
PY  - 2021
JO  - Nature communications
DO  - 10.1038/s41467-021-22446-z
UR  - https://doi.org/10.1038/s41467-021-22446-z
ER  -

APA

C, A., AM, S., P, J., J, V. H., S, A., EF, A., BS, A., J, A., RK, A., DC, A., YM, A., S, A., LR, B., AW, B., L, B., T, B., MAH, B., CP, C., TC, C., SH, C., CY, C., WS, C., YZ, C., LN, C., O, D., FF, D. A. E. V., MVG, D. L., GC, D. M., L, D., V, D., A, E., AC, G., CM, H., T, H., AIM, H., YW, H., B, I., R, J., F, J., KS, K., PG, K., B, K., CY, K., T, L., YC, L., WP, L., TH, L., MN, L., C, M., BJ, M., P, M., WM, M., SC, M., A, M., MJ, M., S, M., S, N., S, N., A, N., LA, N., SM, O., NL, O., L, P., R, P., L, P., A, R., NE, R., FW, R., S, R., R, R., R, R., H, R., VS, S., TB, S., M, S., S, S., JE, S., I, T., AB, T., TY, T., NA, T., RJ, U., SR, W., SA, W., JM, W., M, V., HL, W., R, W., FG, Z., W, Z., D, M., SN, G., JPA, I., & LG, H. (2021). Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.. Nature communications. https://doi.org/10.1038/s41467-021-22446-z

Source records